| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.0094 |
0.9 |
| mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |